Welcome to our dedicated page for Plexus SEC filings (Ticker: PLXS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading Plexus Corp’s disclosures can feel like assembling a multilayer circuit board—every footnote, customer-concentration table, and segment margin matters. Yet the company’s 10-K often exceeds 250 pages and its 8-K material events arrive without notice.
Stock Titan eliminates the guesswork. Our AI parses each Plexus SEC filing the moment it hits EDGAR, then delivers plain-English highlights so you can:
- See Plexus insider trading Form 4 transactions and receive Plexus Form 4 insider transactions real-time alerts.
- Compare backlog trends inside the Plexus quarterly earnings report 10-Q filing.
- Review supply-chain risk updates with our Plexus 8-K material events explained summaries.
Need to understand cost-plus defense contracts or how healthcare orders affect margins? Our AI-powered summaries point you straight to the notes that matter, making Plexus SEC filings explained simply.
For deeper dives, open the original documents beside concise annotations: the Plexus annual report 10-K simplified section decodes multi-segment revenue, while our proxy overview answers your search for Plexus proxy statement executive compensation. Investors tracking leadership moves can monitor Plexus executive stock transactions Form 4 without scanning dozens of PDFs.
Whether you’re researching contract manufacturing exposure or seeking a quick Plexus earnings report filing analysis, Stock Titan’s real-time data and expert context let you act with clarity, not guesswork.
Plexus Corp (PLXS) Form 144 notice: A proposed sale of 3,000 shares of common stock is reported through Morgan Stanley Smith Barney LLC, with an aggregate market value of $417,000 and approximately 26,986,726 shares outstanding. The approximate date of sale is 08/28/2025 on NASDAQ. The securities were acquired from the issuer as restricted stock and performance shares on 01/27/2023 (1,480 shares), 01/25/2024 (155 shares), and 02/13/2024 (1,365 shares). No securities of the issuer were reported sold by the person in the past three months, and the filer certifies they are not aware of undisclosed material adverse information.
Plexus Corp (PLXS) insider sale disclosed. Angelo M. Ninivaggi Jr., listed as Director and Executive Vice President/CAO/General Counsel & Secretary, sold 1,576 shares of Plexus common stock on 08/25/2025 at a price of $137.775 per share. After the transaction he beneficially owned 24,495 shares. The Form 4 was signed by an attorney-in-fact on 08/27/2025.
Plexus Corp (PLXS) Form 144 - A holder has filed notice to sell 2,500 shares of Plexus common stock on or about 08/27/2025, with an aggregate market value of $344,275.00 based on the filing. The securities were acquired as performance shares on 02/12/2019. The filing states there are 26,986,726 shares outstanding and lists the proposed broker as Morgan Stanley Smith Barney LLC on NASDAQ. The notice also reports that Patrick Jermain sold 2,178 shares on 08/06/2025 for gross proceeds of $284,054.76. The filer certifies they are not aware of undisclosed material adverse information.
Plexus Corp (PLXS) Form 144 notice shows a proposed sale of 1,576 common shares through Morgan Stanley Smith Barney on 08/25/2025 with an aggregate market value of $217,133.40. The shares were acquired as performance shares from the issuer on 02/13/2024. The filing also reports a prior sale by Angelo M. Ninivaggi of 2,058 common shares on 05/27/2025 for gross proceeds of $272,112.88. The issuer's total shares outstanding are reported as 26,986,726, and the proposed sale lists NASDAQ as the exchange. The filer certifies no undisclosed material adverse information is known.
Oliver K. Mihm, Executive Vice President & Chief Operating Officer of Plexus Corp. (PLXS), reported changes in his beneficial ownership in a Form 4 filing. The filing shows 981 shares held indirectly in the Plexus 401(k) plan, a sale of 2,102 shares on 08/15/2025 at $130.43 per share, and a gift of 200 shares on 08/18/2025. After the reported transactions, Mihm beneficially owned 20,955 shares directly.
The filing states the 981 shares were held in the company 401(k) plan per the plan trustee and that the 200 shares were given as a bona fide gift. The form was signed on behalf of Mihm by an attorney-in-fact on 08/19/2025. No derivative transactions or option exercises are listed.
Plexus Corporation (PLXS) Form 144: A notice of proposed sale reports 2,102 common shares to be sold through Morgan Stanley Smith Barney LLC on NASDAQ with an approximate sale date of 08/15/2025. The filing lists an aggregate market value of $274,163.86 and 26,986,726 shares outstanding. The shares were acquired as performance shares on 11/16/2023 from the issuer and were fully paid on that date. The filer reports no securities sold in the past three months. The notice includes the standard signer representation that the selling person is not aware of any undisclosed material adverse information about the issuer.
Plexus Corp (PLXS) officer reported an insider sale and existing plan holdings. The Form 4 shows an 08/06/2025 sale of 2,178 shares of Plexus common stock at $130.42 per share. After that disposition the reporting person is shown as directly owning 23,459 shares. The filing also discloses 3,719 shares held indirectly in the Plexus 401(k) Retirement Plan per the plan trustee.
The reporting person is identified as an officer serving as Executive Vice President & Chief Financial Officer. No derivative securities or option transactions are reported. The Form 4 is signed by the reporting person via an attorney-in-fact.
FAQ
What is the current stock price of Plexus (PLXS)?
What is the market cap of Plexus (PLXS)?
